Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT05827081

1 development in the corpus

NCT05827081

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · PHASE 3 TRIAL

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

ClinicalTrials.gov

This is a trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for assessment.

PreliminaryNCT05827081 Ribociclib Ansastrozole

Reported

Planned enrollment1400

Primary outcome measureInvasive Breast Cancer Free Survival (iBCFS…

Study phasePhase IIIb

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support